BIOMAT Database Logo BIOMAT Database Logo

Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation. 1988

S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
Institute of Nephrology, University Brescia, Italy.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D014652 Vascular Diseases Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body. Disease, Vascular,Diseases, Vascular,Vascular Disease

Related Publications

S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
Long-term results after stopping cyclosporine at 6 months following renal transplantation.
August 1998, Transplantation proceedings,
S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
A randomised, prospective study on the conversion from cyclosporine-prednisone to cyclosporine-azathioprine at 6 months after renal transplantation.
January 1998, Transplant international : official journal of the European Society for Organ Transplantation,
S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
Calcium antagonist therapy prevents chronic cyclosporine nephrotoxicity after renal transplantation: a prospective study.
February 1992, Transplantation proceedings,
S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation.
May 2000, Transplantation,
S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide.
February 1991, Transplantation proceedings,
S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
Randomized prospective trial of elective cyclosporine withdrawal from triple therapy at 6 months after cadaveric renal transplantation.
February 1991, Transplantation proceedings,
S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
Controlled cyclosporine conversion at three months after renal transplantation. Long-term results.
November 1988, Transplantation,
S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
Enzymatic markers of cyclosporine nephrotoxicity in patients after renal transplantation.
January 1999, International urology and nephrology,
S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
[Follow-up after renal transplantation].
June 2009, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
S Savoldi, and F Scolari, and S Sandrini, and P Scaini, and G Sacchi, and R Tardanico, and C Camerini, and B Salerni, and G Tonini, and U De Nobili
Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.
February 1989, Transplantation proceedings,
Copied contents to your clipboard!